We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$38.5B
AUM Growth
+$4.48B
(+13%)
Cap. Flow
+$4.55B
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
2,364
New
149
Increased
1,180
Reduced
895
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$275M |
| 2 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$221M |
| 3 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$193M |
| 4 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$188M |
| 5 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$230M |
| 2 |
Spectrum Brands
SPB
|
+$81.6M |
| 3 |
Chevron
CVX
|
+$79.8M |
| 4 |
Pfizer
PFE
|
+$66.7M |
| 5 |
K
Kellanova
K
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.09% |
| 2 | Consumer Discretionary | 10.38% |
| 3 | Technology | 9.81% |
| 4 | Consumer Staples | 7.93% |
| 5 | Communication Services | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
AES
AES
$10.6B
| $15.5M | 0.04% |
1,167,390
+436,448
| +60% | +$5.86M |
|
552
Reinsurance Group of America
RGA
$15.7B
| $15.5M | 0.04% |
163,116
+39,321
| +32% | +$3.7M |
|
553
FirstEnergy
FE
$28.9B
| $15.5M | 0.04% |
474,681
-248,359
| -34% | -$8.69M |
|
554
Microchip Technology
MCHP
$42.8B
| $15.3M | 0.04% |
645,600
+22,604
| +4% | +$549K |
|
555
Moody's
MCO
$81.7B
| $15.3M | 0.04% |
141,751
+107,021
| +308% | +$11.5M |
|
|
STI
556
DELISTED
SunTrust Banks, Inc.
STI
| $15.3M | 0.04% |
355,049
+70,351
| +25% | +$2.99M |
|
557
Huntington Bancshares
HBAN
$35.1B
| $15.3M | 0.04% |
1,349,250
+182,977
| +16% | +$2.05M |
|
558
Fastenal
FAST
$54B
| $15.3M | 0.04% |
1,446,444
+9,544
| +0.7% | +$100K |
|
|
PRA
559
DELISTED
ProAssurance
PRA
| $15.2M | 0.04% |
329,969
+97,013
| +42% | +$4.41M |
|
560
Fortune Brands Innovations
FBIN
$6.12B
| $15.2M | 0.04% |
389,006
+12,519
| +3% | +$490K |
|
561
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.24B
| $15.2M | 0.04% |
131,831
-2,463
| -2% | -$289K |
|
562
Ventas
VTR
$48.9B
| $15.2M | 0.04% |
214,261
-74,532
| -26% | -$5.82M |
|
563
Oil States International
OIS
$522M
| $15.2M | 0.04% |
407,950
+90,125
| +28% | +$3.79M |
|
564
Dr. Reddy's Laboratories
RDY
$9.82B
| $15.2M | 0.04% |
1,371,680
+811,200
| +145% | +$8.96M |
|
|
DISH
565
DELISTED
DISH Network Corp.
DISH
| $15.1M | 0.04% |
222,827
-146,430
| -40% | -$10.2M |
|
566
Flowserve
FLS
$9.25B
| $15.1M | 0.04% |
286,502
+84,674
| +42% | +$4.72M |
|
567
Omega Healthcare
OHI
$15.4B
| $15.1M | 0.04% |
439,455
-17,924
| -4% | -$658K |
|
568
Macerich
MAC
$7.32B
| $15M | 0.04% |
201,662
+34,597
| +21% | +$2.8M |
|
569
Marvell Technology
MRVL
$174B
| $15M | 0.04% |
1,138,801
+250,617
| +28% | +$3.59M |
|
570
Dolby
DLB
$4.72B
| $15M | 0.04% |
376,835
+253,037
| +204% | +$10M |
|
|
CYS
571
DELISTED
CYS Investments Inc.
CYS
| $14.9M | 0.04% |
1,929,326
+120,980
| +7% | +$1.06M |
|
572
Healthpeak Properties
DOC
$15.4B
| $14.9M | 0.04% |
448,396
-25,915
| -5% | -$943K |
|
573
Mercury Insurance
MCY
$5.94B
| $14.9M | 0.04% |
267,520
+71,574
| +37% | +$4.03M |
|
574
EQT Corp
EQT
$33.2B
| $14.9M | 0.04% |
335,923
-120,311
| -26% | -$5.64M |
|
575
British American Tobacco
BTI
$132B
| $14.9M | 0.04% |
274,776
-9,704
| -3% | -$535K |
|
Similar funds
DAM
First Trust Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, First Trust Advisors held 2,364 positions worth $38.5B, up 13% from $34B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
First Trust Advisors deployed $4.55B of net new capital in Q2 2015, opening 149 new positions and adding to 1,180 existing holdings. Its largest new stake was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Chevron, an estimated $79.8M trimmed.
- First Trust Advisors's largest Q2 2015 buy was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q2 2015, an estimated $275M increase.
- First Trust Advisors's biggest Q2 2015 reduction was Chevron, cutting an estimated $79.8M.
- First Trust Advisors fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $230M.
- First Trust Advisors's ten largest holdings make up 14% of its $38.5B portfolio in Q2 2015.
- First Trust Advisors opened 149 new positions and closed 134 in Q2 2015.
- First Trust Advisors's portfolio value rose 13% quarter-over-quarter to $38.5B.
Based on First Trust Advisors's 13F filing for Q2 2015, filed 4 Aug 2015.